“…The reported prevalence of ASO antibodies ranges from 29-69% in TS to 18-52% in healthy controls (Cardona and Orefici, 2001; Kiessling et al, 1993, 1994; Müller et al, 2000; Singer et al, 1998; Murphy et al, 1997; Morshed et al, 2001; Church et al 2003; Rizzo et al, 2006). The prevalence of antibodies to DNase B ranges from 13-85% and from 8-59% for TS and controls, respectively (Kiessling et al, 1994, Müller et al, 2000; Singer et al, 1998; Murphy et al, 1997, Morshed et al, 2001). One large, long term, population-based follow up study of children after GAS infection found a strong relationship with behavior and non tic-like motor changes but no association specifically with tics (Murphy et al 2007).…”